MiMedx Group (MDXG) Stock Price Down 0.5%

MiMedx Group Inc (NASDAQ:MDXG) fell 0.5% during trading on Thursday . The company traded as low as $5.47 and last traded at $5.53. 109,293 shares changed hands during trading, a decline of 96% from the average session volume of 3,086,706 shares. The stock had previously closed at $5.50.

A number of research firms have recently commented on MDXG. Lake Street Capital set a $12.00 price target on MiMedx Group and gave the stock a “buy” rating in a research report on Wednesday, February 21st. BidaskClub lowered MiMedx Group from a “hold” rating to a “sell” rating in a research report on Wednesday, February 28th. Craig Hallum reaffirmed a “buy” rating on shares of MiMedx Group in a research report on Tuesday, February 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of MiMedx Group in a research report on Thursday, March 15th. Finally, ValuEngine lowered MiMedx Group from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 2nd. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $16.00.

The stock has a market cap of $665.10 million, a PE ratio of 28.52, a P/E/G ratio of 0.78 and a beta of 1.53.

A number of institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in MiMedx Group by 1.1% in the 4th quarter. BlackRock Inc. now owns 13,607,325 shares of the medical equipment provider’s stock valued at $171,588,000 after buying an additional 147,214 shares during the last quarter. Consonance Capital Management LP acquired a new stake in MiMedx Group in the 4th quarter valued at approximately $75,543,000. Millennium Management LLC raised its position in MiMedx Group by 11.5% in the 4th quarter. Millennium Management LLC now owns 2,193,907 shares of the medical equipment provider’s stock valued at $27,665,000 after buying an additional 226,663 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in MiMedx Group by 4.1% in the 1st quarter. The Manufacturers Life Insurance Company now owns 1,462,689 shares of the medical equipment provider’s stock valued at $10,195,000 after buying an additional 57,231 shares during the last quarter. Finally, Senzar Asset Management LLC raised its position in MiMedx Group by 24.2% in the 1st quarter. Senzar Asset Management LLC now owns 902,100 shares of the medical equipment provider’s stock valued at $6,288,000 after buying an additional 175,800 shares during the last quarter. 75.37% of the stock is currently owned by institutional investors and hedge funds.

About MiMedx Group

MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts.

Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply